Stat3 Is a Negative Regulator of Intestinal Tumor Progression in ApcMin Mice

Mónica Musteanu(Universidad Complutense de Madrid), Robert Eferl(Comprehensive Cancer Center Vienna)
Gastroenterology
December 5, 2009
10.1053/j.gastro.2009.11.049
Cited by 173

Related Papers

Abstract B025: The RAF/MEK clamp avutometinib (VS-6766) enhances antitumor efficacy of KRAS G12C and G12D inhibitors through vertical inhibition of RAS, RAF and MEK. </title>
|Molecular Cancer Research|2023|3
Abstract 402: Dual RAF/MEK inhibitor VS-6766 enhances antitumor efficacy of KRAS G12C inhibitors through vertical inhibition of RAS, RAF and MEK
|Cancer Research|2022|2